Comparing gummy vitamins to tablets or capsules? Don't just look at unit cost. Manufacturers know: that number rarely tells the full story.
Ask a better question: what does it cost to make, package, test, store, and ship a supplement that still meets its label claim and quality standards over its full shelf life? That full-picture view is where gummies and pills separate fast—and where most cost comparisons miss the point.
The Cost Metric Most Brands Miss: Shippable Potency
In real production, you don't just pay for ingredients and a bottle. You pay for everything required to deliver a dose that remains label-compliant and sellable after processing, warehousing, and distribution. Think of it as the economics of shippable potency: the cost of a product that survives the real world without drifting out of spec or becoming a customer service headache.
1) Gummies Start with More Non-Active Material
Tablets and capsules are lean formulas: active ingredients plus small amounts of excipients for flow, compression, and encapsulation. Gummies are different by design—they're built on a confection-style base before you even get to the actives.
That base typically includes multiple components, each with its own sourcing, specification, and handling requirements. More components also mean more variables to control, especially at scale. That translates to more SKUs to manage, more COAs to review, and more opportunities for variability that can slow down production.
2) Yield and Scrap: More Ways to Quietly Lose Money with Gummies
When someone quotes a gummy price versus a tablet price, that number usually assumes ideal output. On the floor, cost is heavily influenced by yield: how much of the batch turns into finished goods you can confidently ship.
Common yield drains in gummy production include moisture targets that miss the mark, deposit weight variation that complicates label accuracy, curing time bottlenecks, cosmetic defects like sticking or clumping, and limited rework options. Tablets and capsules are generally more predictable because the processes are faster and less sensitive to cure time and humidity.
3) Stability Planning Creates an Overage Tax—Higher for Gummies
To keep a supplement compliant through its shelf life, manufacturers often formulate with overages, adding more than the label claim at production to account for expected losses over time. Gummies typically demand more stability planning because the process and finished format are tougher on actives. The stressors are well known: heat, moisture, the acid/sweetener system, and oxygen exposure depending on the package.
How overages change the real cost comparison? Compare two numbers:
- Cost per labeled amount (what the label says)
- Cost per amount actually dosed into the batch (after stability-driven overage)
That gap is often where gummy economics shift.
4) Packaging and Freight: Gummies Cost More to Protect and Ship
Packaging isn't just branding—it's part of your stability system. Gummies are sensitive to moisture and temperature, so packaging decisions become engineering requirements. That means more robust seals, desiccants that must be precisely tuned, and larger bottles that increase freight.
A cleaner way to compare: look at freight per 1,000 servings instead of per bottle. Gummies ship more mass and packaging per serving than tablets or capsules, and those costs add up fast at scale—especially in e-commerce.
5) QA/QC Workload: Gummies Behave Like a Supplement-Food Hybrid
Both gummies and pills need strong quality systems under supplement cGMP. But gummies require more in-process attention because product quality ties directly to moisture management, environmental control, and cosmetic outcomes. That means more in-process checks, greater sensitivity to handling conditions, and more investigations when appearance or pack-out deviates from spec. Even if the final testing panel looks similar on paper, gummy production drives higher operational QA time—and that's a real cost.
6) Throughput and Capacity: Hour-by-Hour Economics Favor Pills
Here's a manufacturing reality that rarely makes it into marketing conversations: time is a cost center. Tablet presses and capsule fillers produce high volumes efficiently. Gummies involve cooking, depositing, and curing steps that take time and space—curing capacity often becomes a bottleneck. So ask not just “What’s the per-bottle price?” but “How many finished, packaged servings can we reliably produce per hour?” That throughput difference often explains why pills win on baseline COGS.
So Which Format Is Cheaper?
For most manufacturers, tablets and capsules win on pure economics because they offer better throughput, lower freight per serving, and fewer pack-out complications. Gummies can still be a smart business decision when the formulation is designed for the format, packaging is engineered early, and the brand values consumer preference enough to justify the added complexity.
How to Run an Apples-to-Apples Comparison with KorNutra
If you want a cost comparison that reflects real manufacturing conditions (not best-case assumptions), ask for these four numbers:
- Fully loaded COGS per 1,000 servings (not per bottle)
- Yield and scrap assumptions—and what variables drive them
- Overage assumptions tied to shelf-life goals and packaging choice
- Landed cost sensitivity to temperature and humidity during storage and shipping
Those questions surface the true cost drivers quickly and help you choose the format based on delivered value—not just a unit price on a spreadsheet.